Exact Mass: 523.0417

Exact Mass Matches: 523.0417

Found 18 metabolites which its exact mass value is equals to given mass value 523.0417, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

C06149

[[3-(2-amino-7-methyl-4-oxo-7,8-dihydro-1H-pteridin-6-yl)-2,3-dihydroxy-butoxy]-hydroxy-phosphoryl] phosphono hydrogen phosphate

C11H20N5O13P3 (523.027)


   

Ceftiofur

3-[(Furan-2-carbonylsulphanyl)methyl]-7-{[(2Z)-1-hydroxy-2-(2-imino-2,3-dihydro-1,3-thiazol-4-yl)-2-(methoxyimino)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C19H17N5O7S3 (523.029)


Veterinary antibacterial agent. Ceftiofur is a fda approved for treatment of respiratory disorders in beef or dairy cattle and pigs Ceftiofur is an antibiotic of the cephalosporin type (third generation), licensed for use in veterinary medicine. It was first described in 1987. It is marketed by pharmaceutical company Pfizer as Excede Veterinary antibacterial agent. FDA approved for treatment of respiratory disorders in beef or dairy cattle and pigs

   
   
   

Ceftiofur

Ceftiofur

C19H17N5O7S3 (523.029)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic CONFIDENCE standard compound; INTERNAL_ID 1051

   

p-HydroxyPiroxicam glucuronide

p-HydroxyPiroxicam glucuronide

C21H21N3O11S (523.0897)


   

3(2H)-Benzoxazolepropanesulfonic acid, 2-[[3-(2-hydroxyethyl)-5-oxo-1-phenyl-2-thioxo-4-imidazolidinylidene]ethylidene]-, monosodium salt

3(2H)-Benzoxazolepropanesulfonic acid, 2-[[3-(2-hydroxyethyl)-5-oxo-1-phenyl-2-thioxo-4-imidazolidinylidene]ethylidene]-, monosodium salt

C23H22N3NaO6S2 (523.0848)


   
   
   
   

Elinogrel

Elinogrel

C20H15ClFN5O5S2 (523.0187)


C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor Elinogrel (PRT060128) is a potent, direct acting, competitive, and reversible platelet P2Y12 antagonist (IC50=20 nM). It is orally and intravenously available and has potent antiplatelet effects[1].

   

Methylmercury glutathione

Methylmercury glutathione

C11H19HgN3O6S (523.0701)


   

S-(3-Iodobenzyl)glutathione

S-(3-Iodobenzyl)glutathione

C17H22IN3O6S (523.0274)


   

gamma-Glutamyl[S-(2-iodobenzyl)cysteinyl]glycine

gamma-Glutamyl[S-(2-iodobenzyl)cysteinyl]glycine

C17H22IN3O6S (523.0274)


   

1-[[2-[5-[3,5-Bis(trifluoromethyl)phenyl]tetrazol-2-yl]acetyl]amino]-3-(4-chlorophenyl)thiourea

1-[[2-[5-[3,5-Bis(trifluoromethyl)phenyl]tetrazol-2-yl]acetyl]amino]-3-(4-chlorophenyl)thiourea

C18H12ClF6N7OS (523.0417)


   

CID1231538

CID1231538

C26H22ClN3O3S2 (523.0791)


CID1231538, a benzothiazole analogue, is a potent GPR35 antagonist (IC50=0.55 μM). GPR35 is a G protein-coupled receptor (GPCR)[1].

   

n-(4-{[(5s,10r)-7,9-dibromo-10-hydroxy-8-methoxy-1-oxa-2-azaspiro[4.5]deca-2,6,8-trien-3-yl]formamido}butyl)ethoxycarboximidic acid

n-(4-{[(5s,10r)-7,9-dibromo-10-hydroxy-8-methoxy-1-oxa-2-azaspiro[4.5]deca-2,6,8-trien-3-yl]formamido}butyl)ethoxycarboximidic acid

C17H23Br2N3O6 (522.9953)


   

n-[4-({7,9-dibromo-10-hydroxy-8-methoxy-1-oxa-2-azaspiro[4.5]deca-2,6,8-trien-3-yl}formamido)butyl]ethoxycarboximidic acid

n-[4-({7,9-dibromo-10-hydroxy-8-methoxy-1-oxa-2-azaspiro[4.5]deca-2,6,8-trien-3-yl}formamido)butyl]ethoxycarboximidic acid

C17H23Br2N3O6 (522.9953)